Article

Prediction of repurposed drugs for treating lung injury in COVID-19

2020-08-26

Abstract excerpt

<h4>Background: </h4> Coronavirus disease (COVID-19) is an infectious disease discovered in 2019 and currently in outbreak across the world. Lung injury with severe respiratory failure is the leading cause of death in COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there still lacks efficient treatment for COVID-19 induced lung injury and acute respiratory failure. <h4>M...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d63033c3-cd3b-5ece-999a-e74e5952f793
DOI: 10.12688/f1000research.23996.2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prediction of repurposed drugs for treating lung injury in COVID-19DOI 10.12688/f1000research.23996.2Read

Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2Semantic proximity Read

Potential therapeutic targets for COVID-19 complicated with pulmonary hypertension: a bioinformatics and early validation studySemantic proximity Read

Drug Repurposing of potential drug targets for treatment of COVID-19Semantic proximity Read

Identification of pulmonary comorbid diseases network based repurposing effective drugs for COVID-19Semantic proximity Read

Bioinformatic approaches towards identification of potential repurposable drugs for COVID-19Semantic proximity Read

Mechanisms and Therapeutic Strategies for Pulmonary Fibrosis Post-COVID-19 ARDS: Insights from Comprehensive BioinformaticsSemantic proximity Read

Assessment of ACE2, CXCL10 and Their co-expressed Genes: An In-silico Approach to Evaluate the Susceptibility and Fatality of Lung Cancer Patients towards COVID-19 InfectionSemantic proximity Read

Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapySemantic proximity Read

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19Semantic proximity Read

Kidney-lung crosstalk during SARS-CoV-2 infection: In silico hypothesis-generating method for COVID-19 modelsSemantic proximity Read

A Connectivity Map-Based Drug Repurposing Study and Integrative Analysis of Transcriptomic Profiling of SARS-CoV-2 InfectionSemantic proximity Read

In silico and in vitro studies of Taiwan Chingguan Yihau (NRICM101) on TNF-α/IL-1β-induced Human Lung CellsSemantic proximity Read